These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12833018)

  • 41. [Giant gravidarum granuloma of the scalp].
    Domínguez-Cherit J; Puebla-Miranda M; Rangel-Gamboa L; Roldán-Marín R
    Gac Med Mex; 2006; 142(5):411-3. PubMed ID: 17128822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome?
    Dereure O; Hillaire-Buys D; Guilhou JJ
    Br J Dermatol; 2004 Jun; 150(6):1228-30. PubMed ID: 15214930
    [No Abstract]   [Full Text] [Related]  

  • 43. Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors.
    Goldman JM; Madrigal JA; Pamphilon D
    Br J Haematol; 2006 Dec; 135(5):651-2. PubMed ID: 17054429
    [No Abstract]   [Full Text] [Related]  

  • 44. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte colony-stimulating factors: finding the right indication.
    Lyman GH; Shayne M
    Curr Opin Oncol; 2007 Jul; 19(4):299-307. PubMed ID: 17545791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutropenia management with granulocyte colony-stimulating factors: from guidelines to nursing practice protocols.
    Dolan S; Crombez P; Munoz M
    Eur J Oncol Nurs; 2005; 9 Suppl 1():S14-23. PubMed ID: 16207534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetics of granulocyte colony-stimulating factor in the human milk of a nursing donor receiving treatment for mobilization of the peripheral blood stem cells.
    Kaida K; Ikegame K; Fujioka T; Taniguchi Y; Inoue T; Hasei H; Tamaki H; Yoshihara S; Kawase I; Ogawa H
    Acta Haematol; 2007; 118(3):176-7. PubMed ID: 17914246
    [No Abstract]   [Full Text] [Related]  

  • 48. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.
    Pachlopnik Schmid JM; Junge SA; Hossle JP; Schneider EM; Roosnek E; Seger RA; Gungor T
    Pediatrics; 2006 May; 117(5):e1049-56. PubMed ID: 16636116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rapidly growing sternal nodule. Granuloma teleangiectaticum].
    Krayenbühl BH; Trüeb RM; Wüthrich B
    Schweiz Med Wochenschr; 1998 Feb; 128(6):216. PubMed ID: 9540145
    [No Abstract]   [Full Text] [Related]  

  • 50. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
    Tuffaha HW; Treish IM; Zaru L
    J Oncol Pharm Pract; 2008 Sep; 14(3):131-8. PubMed ID: 18524866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple erythematous, shiny papules in a child.
    Prates FV; Rocha Bde O; Fernandes JD
    Int J Dermatol; 2014 Dec; 53(12):1423-4. PubMed ID: 25312411
    [No Abstract]   [Full Text] [Related]  

  • 52. Coagulopathy in a patient with X-linked hyper-IgM syndrome who developed Kaposi's sarcoma.
    Nagasawa M; Itoh S; Sawada Y; Morio T; Nonoyama S; Mizutani S
    Am J Hematol; 2004 Feb; 75(2):116-7. PubMed ID: 14755382
    [No Abstract]   [Full Text] [Related]  

  • 53. [A female case of hyper-IgM immunodeficiency syndrome with uncommon skin manifestations].
    Asashima N; Fujimoto M; Jinnin M; Ihn H; Kikuchi K; Takamizawa M; Tamaki K
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):350-5. PubMed ID: 15559325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucocutaneous manifestations of the hyper-IgM immunodeficiency syndrome.
    Chang MW; Romero R; Scholl PR; Paller AS
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):191-6. PubMed ID: 9486673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extramedullary hematopoiesis in a pyogenic granuloma: a case report and review.
    Vega Harring SM; Niyaz M; Okada S; Kudo M
    J Cutan Pathol; 2004 Sep; 31(8):555-7. PubMed ID: 15268711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monozygotic twin brothers with primary immunodeficiency presenting with metastatic adenocarcinoma of unknown primary.
    Wood LA; Venner PM; Pabst HF
    Acta Oncol; 1998; 37(7-8):771-2. PubMed ID: 10051002
    [No Abstract]   [Full Text] [Related]  

  • 57. Profound thrombocytopenia related to G-CSF.
    Kovacic JC; Macdonald P; Freund J; Rasko JE; Allan R; Fernandes VB; Ma D; Moore J; Graham RM
    Am J Hematol; 2007 Mar; 82(3):229-30. PubMed ID: 17034024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor.
    Thompson MA; Dyson SW; Faderl S
    Am J Hematol; 2006 Sep; 81(9):703-5. PubMed ID: 16838322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pyogenic granuloma-like lesion associated with topical tazarotene therapy.
    Dawkins MA; Clark AR; Feldman SR
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):154-5. PubMed ID: 10863244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.